Population Pharmacokinetic Analysis of Anidulafungin, an Echinocandin Antifungal
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2004/06/01
-
Indian UGC (journal)
-
Refrences12
-
Citations136
-
James A. Dowell
-
William Knebel
-
Tom Ludden
-
Marty Stogniew
-
David Krause
-
Tim Henkel
Abstract
Cite
Dowell, James A., et al. “Population Pharmacokinetic Analysis of Anidulafungin, an Echinocandin Antifungal”. The Journal of Clinical Pharmacology, vol. 44, no. 6, 2004, pp. 590-8, https://doi.org/10.1177/0091270004265644.
Dowell, J. A., Knebel, W., Ludden, T., Stogniew, M., Krause, D., & Henkel, T. (2004). Population Pharmacokinetic Analysis of Anidulafungin, an Echinocandin Antifungal. The Journal of Clinical Pharmacology, 44(6), 590-598. https://doi.org/10.1177/0091270004265644
Dowell JA, Knebel W, Ludden T, Stogniew M, Krause D, Henkel T. Population Pharmacokinetic Analysis of Anidulafungin, an Echinocandin Antifungal. The Journal of Clinical Pharmacology. 2004;44(6):590-8.
Journal Categories
Medicine
Public aspects of medicine
Toxicology
Poisons
Medicine
Therapeutics
Pharmacology
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Anidulafungin biotransformation in humans is by degradation not metabolism | 2003 | |||
| Anidulafungin dosage adjustments are not required for patients with hepatic and/or renal impairment | 2003 | |||
| Xpose 2.0 User's Manual | 1997 | |||
| NONMEM Users Guides: Parts I‐VIII | 1988 | |||
| 10.1128/AAC.40.8.1811 |
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Updated antimicrobial dosing recommendations for obese patients | Antimicrobial Agents and Chemotherapy |
| 2024 | |
Echinocandin exposures in obese patients: A scoping review and clinical perspectives | American Journal of Health-System Pharmacy |
| 3 | 2023 |
Optimizing anidulafungin exposure across a wide adult body size range | Antimicrobial Agents and Chemotherapy |
| 1 | 2023 |
Therapeutic Drug Monitoring of the Echinocandin Antifungal Agents: Is There a Role in Clinical Practice? A Position Statement of the Anti-Infective Drugs Committee of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology | Therapeutic Drug Monitoring |
| 1 | 2022 |
Population Analysis of Anidulafungin in Infants to Older Adults With Confirmed or Suspected Invasive Candidiasis | Clinical Pharmacology & Therapeutics |
| 4 | 2020 |
Citations Analysis
The category
Medicine: Therapeutics. Pharmacology 82
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Anidulafungin and was published in 2004. The most recent citation comes from a 2024 study titled Updated antimicrobial dosing recommendations for obese patients. This article reached its peak citation in 2008, with 15 citations. It has been cited in 65 different journals, 3% of which are open access. Among related journals, the Antimicrobial Agents and Chemotherapy cited this research the most, with 21 citations. The chart below illustrates the annual citation trends for this article.